StockNews.com initiated coverage on shares of Check-Cap (NASDAQ:CHEK – Free Report) in a research note issued to investors on Thursday. The brokerage issued a sell rating on the medical research company’s stock.
Check-Cap Stock Down 9.4 %
NASDAQ CHEK opened at $1.15 on Thursday. The firm has a market cap of $6.73 million, a price-to-earnings ratio of -0.38 and a beta of 0.36. The company has a 50-day simple moving average of $1.63 and a two-hundred day simple moving average of $1.97. Check-Cap has a 12-month low of $1.12 and a 12-month high of $3.94.
About Check-Cap
Featured Articles
- Five stocks we like better than Check-Cap
- What is the S&P 500 and How It is Distinct from Other Indexes
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Technology Stocks Explained: Here’s What to Know About Tech
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
- What Makes a Stock a Good Dividend Stock?
- The Downtrend in UPS Stock Isn’t Over Yet
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.